Department of Biostatistics, University of Washington, 3980 15th Avenue NE, Box 351617, Seattle, WA, 98195, USA.
Department of Electrical and Computer Engineering, University of Washington, Seattle, WA, 98195, USA.
J Neurol. 2023 Nov;270(11):5536-5544. doi: 10.1007/s00415-023-11909-6. Epub 2023 Aug 1.
The cysteine-altering variants in NOTCH3 have been suggested to be associated with stroke, dementia, and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), where aberrant blood pressure levels represent the characteristics of these diseases. We aimed to assess whether the cysteine-altering p.Arg544Cys (p.R544C; rs201118034) variant and common single nucleotide variants (SNVs) in NOTCH3 could contribute to systolic and diastolic blood pressure and related phenotypes in the Taiwan Biobank.
We employed a discovery sample of 68,925 individuals, an independent replication sample of 45,676 individuals, and a combined/total sample of 114,601 individuals; all from the Taiwan Biobank. Blood pressure, such as systolic and diastolic blood pressure, was measured for all participants. Association was evaluated using a general linear model, where results were considered statistically significant if the P value < 0.05 divided by the number of independent tests per model.
From our analysis, we identified and replicated three novel candidates for blood pressure that have not previously been reported: the cysteine-altering p.R544C variant for systolic blood pressure, the common SNV rs11669950 for diastolic blood pressure, and the common SNV rs4808235 for diastolic blood pressure. We also generalized two previously identified SNVs (i.e., rs10418305 and rs7408868) in NOTCH3 for blood pressure in European and non-Taiwanese East Asian populations to the Taiwanese population. Moreover, the participants with NOTCH3 p.R544C had an increased stroke frequency (P < 1.0 × 10) and a higher dementia frequency (P = 2.0 × 10) compared with the whole Taiwan Biobank population in the combined/total sample.
NOTCH3 is a strong candidate for a role in stroke, dementia, and CADASIL, which has previously been linked to blood pressure changes. While our preliminary study suggests that NOTCH3 p.R544C may influence blood pressure, stroke, and dementia in the Taiwan Biobank, replication in a well-powered external sample is required. This study also underlines considerable prospects of detecting novel genetic biomarkers in underrepresented worldwide populations.
NOTCH3 中的半胱氨酸变异与中风、痴呆和伴有皮质下梗死和白质脑病的常染色体显性脑动脉病(CADASIL)有关,其中异常的血压水平是这些疾病的特征。我们旨在评估 NOTCH3 中的半胱氨酸变异 p.Arg544Cys(p.R544C;rs201118034)变体和常见的单核苷酸变异(SNVs)是否可以影响台湾生物库中收缩压和舒张压以及相关表型。
我们使用了台湾生物库的 68925 名个体的发现样本、45676 名个体的独立复制样本和 114601 名个体的组合/总样本。所有参与者的血压(如收缩压和舒张压)都进行了测量。使用一般线性模型评估关联,结果被认为在每个模型的独立测试数量除以 0.05 时具有统计学意义。
从我们的分析中,我们确定并复制了三个以前未报道过的血压新候选基因:影响收缩压的半胱氨酸变异 p.R544C、影响舒张压的常见 SNV rs11669950 和影响舒张压的常见 SNV rs4808235。我们还将 NOTCH3 中两个以前确定的 SNVs(即 rs10418305 和 rs7408868)在欧洲和非台湾东亚人群中的血压情况推广到台湾人群中。此外,与整个台湾生物库人群相比,NOTCH3 p.R544C 携带者的中风频率更高(P<1.0×10),痴呆频率更高(P=2.0×10)。
NOTCH3 是中风、痴呆和 CADASIL 的一个强有力的候选基因,这些疾病以前与血压变化有关。虽然我们的初步研究表明,NOTCH3 p.R544C 可能影响台湾生物库中的血压、中风和痴呆,但需要在一个功能强大的外部样本中进行复制。这项研究还强调了在代表性不足的全球人群中检测新型遗传生物标志物的巨大前景。